Mary Kay Bowman Receives 29,346 RSUs at BILL Holdings (BILL)
Rhea-AI Filing Summary
Mary Kay Bowman, listed as an officer and director of BILL Holdings, Inc. (BILL), reported a grant of 29,346 restricted stock units (RSUs) on 09/15/2025. Each RSU converts to one share of common stock and the RSUs carry a $0 per-share grant price. The RSUs vest in four equal quarterly installments over one year beginning November 28, 2025, subject to Ms. Bowman’s continued service on each vesting date. Following the reported grant, Ms. Bowman beneficially owns 29,346 shares directly from this award. The filing was submitted via attorney-in-fact and signed on 09/17/2025.
Positive
- Clear disclosure of RSU amount (29,346), vesting schedule (four equal quarterly installments) and conversion (one RSU = one share)
- Direct beneficial ownership reported following the grant (29,346 shares), improving transparency
Negative
- No performance conditions disclosed; vesting is solely service-based over one year which may be a short retention horizon
- Grant price $0 indicates full-value award but the filing does not state whether other outstanding grants exist for context
Insights
TL;DR: A typical service-based RSU grant of 29,346 shares vests quarterly over one year, aligning executive compensation with retention.
This grant is structured as time-based RSUs with a $0 grant price and four equal quarterly vesting events beginning November 28, 2025. The award size and one-year cliff-with-quarters vesting suggest a short-term retention incentive rather than a long-term multi-year incentive. Reporting shows direct beneficial ownership of 29,346 shares post-grant, indicating these RSUs are not held indirectly. The Form 4 filing is routine, disclosing standard equity compensation for an executive-level officer.
TL;DR: Disclosure is complete for the award: amount, vesting schedule, and service condition are explicitly stated.
The Form 4 identifies the reporting person as an officer and director and specifies the RSU mechanics: conversion to one share each and quarterly vesting over a year starting November 28, 2025. The filing was executed by an attorney-in-fact on 09/17/2025. No additional conditions, performance metrics, or changes to prior holdings are disclosed in this document, so governance implications are limited to routine equity compensation transparency.